Spyre Therapeutics Inc
(FRA:3920)
€
77
(0%)
Market Cap: 6.88 Bil
Enterprise Value: 6.36 Bil
PE Ratio: 0
PB Ratio: 13.80
GF Score: 33/100 Spyre Therapeutics Inc (FRA:3920) Transcripts
- 1